BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28122342)

  • 1. Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis.
    Cao F; Li J; Li A; Li F
    Oncotarget; 2017 Feb; 8(9):15004-15013. PubMed ID: 28122342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society.
    Tsuchida H; Fujii T; Mizuma M; Satoi S; Igarashi H; Eguchi H; Kuroki T; Shimizu Y; Tani M; Tanno S; Tsuji Y; Hirooka Y; Masamune A; Mizumoto K; Itoi T; Egawa S; Kodama Y; Hamada S; Unno M; Yamaue H; Okazaki K;
    Surgery; 2019 Dec; 166(6):997-1003. PubMed ID: 31445763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of peritoneal cytology in potentially resectable pancreatic cancer.
    Yamada S; Fujii T; Kanda M; Sugimoto H; Nomoto S; Takeda S; Nakao A; Kodera Y
    Br J Surg; 2013 Dec; 100(13):1791-6. PubMed ID: 24227366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study.
    Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
    World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should Positive Cytology Revealed by Intraoperative Lavage Preclude Radical Resection in Resectable Pancreatic Cancer?: A Systemic Review and Meta-analysis.
    Li BQ; Wang HY; Li L; Jiang B; Ma CL; Yuan CH; Xiu DR
    Pancreas; 2022 Nov-Dec 01; 51(10):1263-1276. PubMed ID: 37099766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting positive peritoneal cytology in pancreatic cancer.
    O'Halloran EA; Board T; Lefton M; Devarajan K; Dotan E; Meyer J; Reddy SS
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1825-1832. PubMed ID: 33389074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.
    Yamada S; Takeda S; Fujii T; Nomoto S; Kanazumi N; Sugimoto H; Kasuya H; Kodera Y; Nagasaka T; Morita S; Nakao A
    Ann Surg; 2007 Aug; 246(2):254-8. PubMed ID: 17667504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma.
    Ferrone CR; Haas B; Tang L; Coit DG; Fong Y; Brennan MF; Allen PJ
    J Gastrointest Surg; 2006 Dec; 10(10):1347-53. PubMed ID: 17175453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.
    Clark CJ; Traverso LW
    Am J Surg; 2010 May; 199(5):657-62. PubMed ID: 20466112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic indicators in pancreatic cancer patients undergoing total pancreatectomy.
    Maeda S; Ariake K; Iseki M; Ohtsuka H; Mizuma M; Nakagawa K; Morikawa T; Hayashi H; Motoi F; Kamei T; Naitoh T; Unno M
    Surg Today; 2020 May; 50(5):490-498. PubMed ID: 31768656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
    Meszoely IM; Lee JS; Watson JC; Meyers M; Wang H; Hoffman JP
    Am Surg; 2004 Mar; 70(3):208-13; discussion 213-4. PubMed ID: 15055843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of occult tumor cells obtained by peritoneal lavage in patients with resectable pancreatic cancer and no ascites: A systematic review.
    Steen W; Blom R; Busch O; Gerhards M; Besselink M; Dijk F; Festen S
    J Surg Oncol; 2016 Nov; 114(6):743-751. PubMed ID: 27642007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implications of positive peritoneal lavage cytology in potentially resectable pancreatic cancer.
    Yoshioka R; Saiura A; Koga R; Arita J; Takemura N; Ono Y; Yamamoto J; Yamaguchi T
    World J Surg; 2012 Sep; 36(9):2187-91. PubMed ID: 22555286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer.
    Yachida S; Fukushima N; Sakamoto M; Matsuno Y; Kosuge T; Hirohashi S
    Br J Surg; 2002 May; 89(5):573-8. PubMed ID: 11972546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of intraoperative peritoneal cytology after neoadjuvant therapy for potentially resectable pancreatic cancer.
    Aoki S; Mizuma M; Hayashi H; Yoshimachi S; Hata T; Miura T; Takadate T; Maeda S; Ariake K; Kawaguchi K; Masuda K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Motoi F; Unno M
    Pancreatology; 2020 Dec; 20(8):1711-1717. PubMed ID: 33032923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer.
    Iwagami Y; Eguchi H; Wada H; Tomimaru Y; Hama N; Kawamoto K; Kobayashi S; Mori M; Doki Y; Nagano H
    Surg Today; 2015 Apr; 45(4):444-50. PubMed ID: 24975140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
    Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
    Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head.
    Leach SD; Rose JA; Lowy AM; Lee JE; Charnsangavej C; Abbruzzese JL; Katz RL; Evans DB
    Surgery; 1995 Sep; 118(3):472-8. PubMed ID: 7652681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Free intraperitoneal tumors cells in pancreatic cancer--significance for clinical course and therapy].
    Heeckt P; Safi F; Binder T; Büchler M
    Chirurg; 1992 Jul; 63(7):563-7. PubMed ID: 1380421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.